This study aims to reveal the key anti-obesity constituents in AGE and elucidate their inhibitory mechanisms against hPL, which will offer direct evidence to support the anti-obesity and lipid-lowering effects of AGE. This evidence concerns the gene LGALS1 and obesity disorder.